GlassScriptPhysician profile
Scott Schnaible
NPI 1689723694
$14,726.43
in general payments reported to CMS, 2019-2025
24 companies · $2,747 in 2025
The $2,747 reported for 2025 was more than what 96% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,811 · 2022: $2,940 · 2023: $2,955 · 2024: $4,274 · 2025: $2,747.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $8,045 · Travel and Lodging: $1,931.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $8,044.84 |
| Travel and Lodging | $1,930.78 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $9,704.27 | 2021-2025 | Wavewriter Alpha Prime 16, General - Pain Management, Infinion 16 |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $1,841.12 | 2021-2025 | Relistor |
| Saluda Medical Americas, INC. | $845.96 | 2025 | Evoke |
| Collegium Pharmaceutical, INC. | $617.31 | 2021-2025 | Belbuca, Xtampza |
| Abbott Laboratories | $422.07 | 2021-2025 | Proclaim, Eterna |
| Globus Medical, INC. | $268.97 | 2025 | Senza |
| Forte Bio-Pharma LLC | $208.69 | 2021-2024 | Prolate, Nalocet |
| Scilex Pharmaceuticals INC. | $201.79 | 2021-2023 | Ztlido |
| Abbvie INC. | $157.04 | 2022-2025 | |
| Biodelivery Sciences International, INC. | $88.99 | 2021 | |
| Vertex Pharmaceuticals Incorporated | $45.24 | 2024-2025 | |
| Nevro Corp. | $40.14 | 2024 | Senza |
| Amgen INC. | $35.64 | 2021-2025 | Prolia, Evenity |
| Pfizer INC. | $33.79 | 2021 | |
| Stryker Corporation | $32.67 | 2025 | Mild Device Kit |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pacira Pharmaceuticals Incorporated | $28.02 | 2021-2023 | Zilretta, Iovera |
| Spr Therapeutics, INC | $23.09 | 2025 | Sprint Pns System |
| Painteq LLC | $22.65 | 2024 | Painteq |
| Allergan, INC. | $22.02 | 2022 | |
| Grt US Holding, INC. | $21.95 | 2021 | |
| Ibsa Pharma INC. | $18.51 | 2021 | |
| Protega Pharmaceutials INC | $18.48 | 2023 | Roxybond |
| Virtus Pharmaceuticals LLC | $14.09 | 2021 | |
| Horizon Therapeutics Plc | $13.93 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Scott Schnaible listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.